Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Tickers
INCY
KNSA
NBIX
RHHBY
Tags
KNSA
Stocks to Buy
INCY
From
InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
December 11, 2023
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
why it's moving
RHHBY
Market News
From
Benzinga
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
Tickers
NVO
RHHBY
VKTX
Tags
VKTX
RHHBY
NVO
From
Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
December 07, 2023
Tickers
ALT
AZN
LLY
NVO
Tags
ALT
RHHBY
AZN
From
MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Tickers
ALT
JNJ
LLY
NVO
Tags
News
Large Cap
Health Care
From
Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
December 05, 2023
Tickers
ALT
MYNZ
PFE
RHHBY
Tags
Biotech
Benzinga
PFE
From
Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
Health Care
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
wegovy
Novo Nordisk
Ozempic
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
News
Large Cap
Health Care
From
Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Tickers
ABSI
AZN
NVDA
RHHBY
Tags
RHHBY
AZN
Contracts
From
Benzinga
Ignore Crypto: These Stocks Could Make You Rich
November 23, 2023
Tickers
MDT
NEE
RHHBY
Tags
MDT
Recent Press Releases
Market News
From
Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
November 17, 2023
Tickers
CLDX
LUNG
PSTX
RHHBY
Tags
Market News
CLDX
LUNG
From
InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
FDA
Media
General
From
Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
November 10, 2023
Tickers
BIIB
LLY
RHHBY
Tags
BIIB
RHHBY
LLY
From
Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
November 02, 2023
Tickers
REGN
RHHBY
Tags
General
REGN
Briefs
From
Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
General
RHHVF
RHHBF
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
News
Eye care
Equities
From
Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
Tickers
LLY
PFE
RHHBY
Tags
Market News
Recent Press Releases
LLY
From
Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
October 24, 2023
Tickers
PFE
RHHBY
ROIV
XBI
Tags
Recent Press Releases
Market News
ROIV
From
Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
PFE
Today's Market
RHHBY
From
InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
Tickers
PFE
RHHBF
RHHBY
ROIV
Tags
Markets
Asset Sales
Market News
From
Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
RHHBY
PFE
ROIV
From
MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
Tickers
BMY
BNTX
PFE
REGN
Tags
Recent Press Releases
REGN
PFE
From
Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
October 19, 2023
Tickers
PTCT
RHHBY
RPRX
SPX
Tags
RPRX
SPX
PTCT
From
MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
October 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Earnings
Large Cap
From
Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
Tickers
GLUE
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Contracts
why it's moving
From
Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Tickers
BMY
NVO
PRTA
RHHBY
Tags
Top Stories
NVO
Health Care
From
Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023
Tickers
RHHBY
SPX
TPST
Tags
RHHBY
TPST
SPX
From
MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
October 11, 2023
Tickers
RHHBY
TPST
Tags
Today's Market
RHHBY
TPST
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.